Jinhai Medical Technology Limited

SEHK:2225 Stock Report

Market Cap: HK$7.3b

Jinhai Medical Technology Past Earnings Performance

Past criteria checks 0/6

Jinhai Medical Technology's earnings have been declining at an average annual rate of -58.7%, while the Professional Services industry saw earnings growing at 2.6% annually. Revenues have been declining at an average rate of 2.9% per year.

Key information

-58.7%

Earnings growth rate

-58.0%

EPS growth rate

Professional Services Industry Growth23.9%
Revenue growth rate-2.9%
Return on equity-28.3%
Net Margin-17.0%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Why We're Not Concerned About Jinhai Medical Technology Limited's (HKG:2225) Share Price

Oct 06
Why We're Not Concerned About Jinhai Medical Technology Limited's (HKG:2225) Share Price

The CEO Of Jinhai Medical Technology Limited (HKG:2225) Might See A Pay Rise On The Horizon

Jun 19
The CEO Of Jinhai Medical Technology Limited (HKG:2225) Might See A Pay Rise On The Horizon

Investors Appear Satisfied With Jinhai Medical Technology Limited's (HKG:2225) Prospects As Shares Rocket 26%

May 13
Investors Appear Satisfied With Jinhai Medical Technology Limited's (HKG:2225) Prospects As Shares Rocket 26%

Subdued Growth No Barrier To Jinhai Medical Technology Limited (HKG:2225) With Shares Advancing 31%

Mar 17
Subdued Growth No Barrier To Jinhai Medical Technology Limited (HKG:2225) With Shares Advancing 31%

What Jinhai International Group Holdings Limited's (HKG:2225) 50% Share Price Gain Is Not Telling You

Jan 31
What Jinhai International Group Holdings Limited's (HKG:2225) 50% Share Price Gain Is Not Telling You

Here's What's Concerning About Jinhai International Group Holdings' (HKG:2225) Returns On Capital

Jun 06
Here's What's Concerning About Jinhai International Group Holdings' (HKG:2225) Returns On Capital

Be Wary Of Jinhai International Group Holdings (HKG:2225) And Its Returns On Capital

Mar 07
Be Wary Of Jinhai International Group Holdings (HKG:2225) And Its Returns On Capital

Revenue & Expenses Breakdown

How Jinhai Medical Technology makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SEHK:2225 Revenue, expenses and earnings (SGD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2460-10260
31 Mar 2453-7210
31 Dec 2346-3170
30 Sep 2333-2140
30 Jun 23200110
31 Mar 23210100
31 Dec 22220100
30 Sep 22250100
30 Jun 2227090
31 Mar 2224090
31 Dec 2122090
30 Sep 2120090
30 Jun 2118190
31 Mar 21201100
31 Dec 20221110
30 Sep 20311120
30 Jun 20400120
31 Mar 20460130
31 Dec 1952-1130
30 Sep 1951-1130
30 Jun 1951-2130
31 Mar 1949-3130
31 Dec 1847-4130
30 Sep 1846-2110
30 Jun 1844-190
31 Mar 1844180
31 Dec 1744270
31 Dec 1645780
31 Dec 1546680
31 Dec 1445490

Quality Earnings: 2225 is currently unprofitable.

Growing Profit Margin: 2225 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 2225 is unprofitable, and losses have increased over the past 5 years at a rate of 58.7% per year.

Accelerating Growth: Unable to compare 2225's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 2225 is unprofitable, making it difficult to compare its past year earnings growth to the Professional Services industry (60.6%).


Return on Equity

High ROE: 2225 has a negative Return on Equity (-28.25%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies